Article
Prognostic value of lymphoid marker CD7 expression in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in first morphological complete remission.
International journal of hematology - 1 Oct 2021
Lv Kangkang, Cai Chengsen, Chen Jia, Xu Mimi, Wan Li, Zhou Meng, Du Yuanyuan, Ma Xiao, Wu Xiaojin, Tang Xiaowen, Qiu Huiying, Wu Depei, Han Yue, Liu Yuejun
Abstract excerpt
Although defined as a lymphoid surface marker, CD7 is aberrantly expressed on a subtype of acute myeloid leukemia cells and appears to be associated with an inferior response to chemotherapy. Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative modality but no data has been reported in CD7-positive AML patients. We performed a retrospective analysis involving 141 AML patients who...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.